Argentarii’s Novartis NVS Stock Holding History

Argentarii’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238K	Buy	1,561 +19	+1%	+$2.91K	0.08%	180
2025 Q4	$213K	Buy	+1,542	New	+$202K	0.07%	191

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Argentarii's NVS Position: Q1 2026 in Review

Argentarii increased its Novartis (NVS) stake by 1.2% in Q1 2026, buying an estimated $2.91K and bringing the position to 1,561 shares worth $238K. The position accounts for 0.08% of the portfolio, ranked #180.

Argentarii first reported a position in NVS in Q4 2025 and has held it in 2 quarters since. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Argentarii held 1,561 shares of Novartis worth $238K as of Q1 2026.
Argentarii bought 19 Novartis shares in Q1 2026, an estimated $2.91K.
Novartis made up 0.08% of Argentarii's portfolio in Q1 2026, its #180 holding.
Argentarii first reported a position in Novartis in Q4 2025 and has held it in 2 quarters since.
1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.